Oligonucleotide compositions for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2008240673 (hide)

Owner VIB vzw Katholieke Universiteit Leuven, K.U.Leuven R & D

Inventors De Strooper, Bart; Hebert, Sebastien

Agent Davies Collison Cave

Pub. Number AU-A-2008240673

PCT Pub. Number WO2008/129023

Priority 07106482.8 19.04.07 EP

Filing date 21 April 2008

Wipo publication date 30 October 2008

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/129023 Priority application(s): WO2008/129023

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240677-Moisture resistant wafer

2008240670-Vaccination regimen for b-cell vaccines